The effiectiveness of Oxytocin nasal spray on behavioral symptoms in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250906067132N1

Enrollment

Registered

2025-10-22

Start date

2025-10-22

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HYPERACTIVITY IMPULSIVITY DISORDER. Attention-deficit hyperactivity disorder, predominantly inattentive type

Interventions

Intervention 1: Intervention group: Children with attention deficit/hyperactivity disorder who have been treated with stimulants but have not responded adequately will be treated with oxytocin nasal s

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1- Consent and informed willingness to participate in the study from parents2- Attention deficit/hyperactivity disorder3- Stability of the patient's medications in terms of type, dose, effect, etc.4- Age 6-12 years5- Connors score above 34 6-People who have undergone standard treatment in the past but have not had a complete or partial recovery will be included in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Studying the effect of oxytocin nasal spray on behavioral symptoms in children with attention deficit/hyperactivity disorder. Timepoint: 0, 4, and 8 weeks. Method of measurement: Using the Connors Parent-Teacher Questionnaire and the Karim Savari Mobile Phone Addiction Inventory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactnasrin naeimiyan

Kashan University of Medical Sciences

Kargarnejad@kaums.ac.ir+98 31 5558 9211

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026